Peripheral Blood Markers Predictive of Progression-Free Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Treated With PD-1 Inhibitors Plus Chemotherapy as First-Line Therapy-Reference-Cited by-同舟云学术

Peripheral Blood Markers Predictive of Progression-Free Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Treated With PD-1 Inhibitors Plus Chemotherapy as First-Line Therapy

Published:2022-10-03 Issue:1 Volume:75 Page:207-218
ISSN:0163-5581
Container-title:Nutrition and Cancer
language:en
Short-container-title:Nutrition and Cancer

Author:

Chen Wei¹^ORCID,Li Dapeng¹,Bian Xuyu¹,Wu Yan¹,Xu Mengdan¹,Wu Mengyao¹,Tao Min¹²

Affiliation:

1. Department of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, China

2. Department of Oncology, DuShu Lake Hospital Affiliated to Soochow University, Suzhou, China

Funder

National Natural Science Foundation of China

the Science and Technology Plan Project of Suzhou

Beijing Xisike Clinical Oncology Research Foundation

Research Grant of BeiGene

Horizontal Research Foundation of Soochow University

Medical and Health Technology Innovation Application Project of Suzhou

Publisher

Informa UK Limited

Subject

Cancer Research,Nutrition and Dietetics,Oncology,Medicine (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/01635581.2022.2123533

Reference39 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Epidemiology of Esophageal Squamous Cell Carcinoma

3. Epidemiology of Esophageal Cancer in Japan and China

4. Management of Patients With Adenocarcinoma or Squamous Cancer of the Esophagus

5. A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy;Cell Reports;2024-03

2. Autophagy Inhibition and Sensitization to Cisplatin in Esophageal Cancer Stem-Like Cells via All-trans Retinoic Acid-induced miR-30a;Current Medicinal Chemistry;2024-01-20

3. Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors;Frontiers in Immunology;2023-07-21